BILL · 2017–18 SESSION

SB 6028: Rx drug monitoring program

Concerning the prescription drug monitoring program.

Summary

  • Creates requirements for the review of the patient's prescription monitoring information when prescribing an opiate or benzodiazepine.
  • Defines the term practitioner for the purposes of the prescription monitoring program.

From the Senate Bill Report (Orig.) (SB 6028), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 8, 2018
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Kevin Van De Wege (D-24)
Introduced
January 8, 2018 in the Senate
Last action
January 8, 2018
Requested by
State agency
Companion bill
HB 2325
Budget
Has a fiscal note

AN ACT Relating to the prescription drug monitoring program;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. First reading, referred to Health & Long Term Care.
  2. Prefiled for introduction.

SB 6028 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page